Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 17 - Drugs for dermatological disorders
Patents for A61P 17 - Drugs for dermatological disorders (106,455)
06/1995
06/22/1995WO1995016659A1 Novel retinoid conjugate compounds and methods for treating skin aging
06/22/1995WO1995010271A3 Phenylacetate and derivatives alone or in combination with other compounds against neoplastic conditions and other disorders
06/22/1995DE4342560A1 Use of 1,4,5,6-tetra:hydro-4-pyrimidine carboxylic acid derivs. in cosmetics
06/22/1995CA2178964A1 Novel retinoid conjugate compounds and methods for treating skin aging
06/22/1995CA2178090A1 Vitamin d amine and amide derivatives
06/22/1995CA2176247A1 Platelet activating factor antagonists: imidazopyridine indoles
06/22/1995CA2138511A1 Methods of inhibiting atrophy of the skin and vagina
06/22/1995CA2138498A1 Methods of inhibiting hirsutism and alopecia in women
06/22/1995CA2138491A1 Methods of inhibiting seborrhea and acne
06/22/1995CA2138454A1 Methods of inhibiting imperfect tissue repair
06/21/1995EP0658553A1 Polycyclic aromatic compounds, pharmaceutical compositions containing them and uses thereof
06/21/1995EP0658309A1 Liquid disinfectant composition and its uses
06/21/1995EP0658108A1 X-hydroxy saturated fatty acids for the treatment of corns and calluses
06/21/1995EP0658099A1 Anti-free-radical topical composition based on a superoxide dismutase and a phosphonic derivative.
06/21/1995EP0642346A4 Solid, storage-stable, germicidal, pre-iodine composition.
06/20/1995US5426197 Antiinflammatory, antiallergy or antitumor agents
06/16/1995CA2137897A1 Biaromatic compounds derived from amides; pharmaceutical and cosmetic compositions containing the same and their uses
06/16/1995CA2137896A1 Propynyl biaromatic compounds; pharmaceutical and cosmetic compositions containing the same and their uses
06/16/1995CA2137739A1 Polycyclic aromatic compounds; pharmaceutical and cosmetic compositions containing the same and their use
06/15/1995WO1995016033A1 C5a RECEPTOR ANTAGONISTS HAVING SUBSTANTIALLY NO AGONIST ACTIVITY
06/15/1995WO1995015953A1 Novel substituted oxazolidines
06/15/1995WO1995015950A1 Compounds
06/15/1995WO1995015760A1 Method of lowering serum cholesterol levels with 2,6-di-alkyl-4-silyl-phenols
06/15/1995CA2177840A1 Cs-1 peptidomimetics, compositions and methods of using the same
06/15/1995CA2176825A1 C5a receptor antagonists having substantially no agonist activity
06/14/1995EP0657458A1 Protein kinase C inhibitors
06/14/1995EP0656944A1 Human melanocyte stimulating hormone receptor
06/14/1995EP0656906A1 A novel endothelial cell molecule mediating lymphocyte binding in man
06/14/1995EP0656774A1 Cosmetic and dermatological sunscreen compositions containing thiols and/or thiol derivates.
06/14/1995EP0656773A1 Use of radical catchers as immunomodulating agents in cosmetic and dermatological compositions.
06/14/1995CN1103578A Hair restorer and its preparation
06/13/1995US5424298 Topical powder compositions containing a cyclic AMP derivative
06/08/1995WO1995015339A1 Antagonists to chaperonin 10
06/08/1995WO1995015338A1 Chaperonin 10
06/08/1995WO1995015309A1 Dp-iv-serine protease inhibitors
06/08/1995WO1995015173A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/08/1995WO1995015172A1 Extract from the leaves of gingko biloba
06/08/1995WO1995015148A1 Topical preparations containing l-arginine
06/08/1995WO1995015147A1 Use of l-arginine, l-ornithine or l-citrulline and topical preparations with these substances
06/08/1995WO1995011309A3 A novel nuclear mitotic phosphoprotein: mitosin
06/08/1995CA2178066A1 Dp-iv-serine protease inhibitors
06/08/1995CA2177825A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof
06/07/1995EP0656213A1 Treatment of conditions and disease
06/07/1995EP0656176A1 Pectin process and composition
06/07/1995EP0655921A1 Novel glucan preparation
06/07/1995EP0655907A1 Use of diacylolycerols for increasing the melanin content in melanocytes
06/07/1995CN1103533A Biologically active ureido derivatives useful as antimetastatic agents
06/07/1995CN1103402A Substituted pyrroles
06/07/1995CN1103291A Preparation for skin and mucous membrane
06/06/1995US5422371 Contacting a cell with a fatty acid or fatty alcohol to prevent reduction of testosterone to 5a-dihydrotestosterone
06/06/1995US5422342 A hydrolase inhibitor comprising a protected oligopeptides for treating fibrose of lungs, liver and skins, atherosclerosis
06/06/1995US5422103 Wound healing agents for burns, bed sores; blended with dextran
06/06/1995US5422102 Diclofenac or salt with nonionic polymer of hydroxypropyl and/or hydroxyethyl cellulose; percutaneous adsorption
06/06/1995US5422100 Method and product for treating skin afflictions
06/06/1995CA2044795C Dermatological composition based on an aqueous phase
06/06/1995CA1335792C Method and dosage form using an antagonist to gamma interferon to control mhc-associated autoimmune disease
06/06/1995CA1335789C Fatty acid compositions
06/01/1995WO1995014714A1 Novel integrin-binding peptides
06/01/1995WO1995014681A1 Isoxazoline compounds as antiinflammatory agents
06/01/1995WO1995014680A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995WO1995014667A1 Substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995WO1995014464A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2224051A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2224049A1 Intermediates for producing substituted indoles as phosphodiesterase type iv inhibitors
06/01/1995CA2177375A1 3-aryl-2-isoxazolines as antiinflammatory agents
06/01/1995CA2177289A1 Ssi tyrphostins and pharmaceutical compositions
06/01/1995CA2177070A1 Novel integrin-binding peptides
05/1995
05/31/1995EP0655442A1 Piperazine derivatives as Tachykinin antagonists
05/31/1995EP0655088A1 Oligonucleotides having chiral phosphorus linkages
05/31/1995EP0654997A1 Compositions of substituted azaspiranes and methods of treating psoriasis therewith
05/31/1995EP0576420B1 Novel derivative of caffeic acid, oraposide, cosmetic or pharmaceutical, particularly dermatological, composition containing it
05/31/1995CN1102992A Liquid medicine for chilblain and preparing process
05/30/1995US5420287 1,2 diarylcyclopentenyl compounds for the treatment of inflammation
05/30/1995US5420273 Condensed heterocyclic compounds
05/30/1995US5420158 Melatonin activity
05/30/1995US5420131 Platelet activating factor antagonist or 5-lipoxygenase inhibitors
05/30/1995US5420106 Method and composition having enhanced alpha-hydroxy acid skin permeation and retention
05/30/1995CA2136712A1 Piperazine derivatives
05/26/1995WO1995014017A1 Non-peptide tachykinin receptor antagonists
05/26/1995WO1995013830A1 Method for inhibiting angiogenesis using heparinase
05/26/1995WO1995013826A1 Preventive and remedy for allergic disease
05/26/1995WO1995013806A1 Compositions containing zinc linoleate for the treatment of skin disorders
05/26/1995WO1995013803A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995WO1995013792A1 Cosmetic method for treatment of skin
05/26/1995WO1995013789A1 Cosmetic method for treatment of skin
05/26/1995WO1995013701A1 Novel fas protein and methods of use thereof
05/26/1995CA2176934A1 Method for inhibiting angiogenesis using heparinase
05/26/1995CA2176735A1 Non-peptide tachykinin receptor antagonists
05/26/1995CA2176575A1 Novel fas protein and methods of use thereof
05/26/1995CA2176143A1 Blocking induction of tetrahydrobiopterin to block induction of nitric oxide synthesis
05/26/1995CA2175813A1 Cosmetic method for treatment of skin
05/26/1995CA2175676A1 Cosmetic method for treatment of skin
05/26/1995CA2109989A1 Polymerized collagen-based anti-fibroid composition
05/24/1995EP0654467A2 Vitamin D3 analogs
05/24/1995EP0653940A1 Glial mitogenic factors, their preparation and use
05/24/1995EP0653938A1 Topical composition
05/24/1995EP0586392B1 Method for separating a vegetable compound
05/24/1995EP0357630B1 Combination of minoxidil and an anti-inflammatory agent for treating patterned alopecia
05/24/1995DE4339751A1 Treating skin disease such as acne
05/24/1995DE4339750A1 Treating skin disease such as acne
1 ... 1010 1011 1012 1013 1014 1015 1016 1017 1018 1019 1020 1021 1022 1023 1024 1025 1026 1027 1028 1029 1030 ... 1065